<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28855/results-of-the-apact-study-phase-iii-trial-of-adjuvant-nab-paclitaxel?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Results of the APACT Study: Phase III Trial of Adjuvant N...

Name: Results of the APACT Study: Phase III Trial of Adjuvant N...
Uploaded: 2019-06-25T07:14:48
Duration: 2 min 25 s
Description: Thomas A. Abrams, Senior Physician and Assistant Medical Professor at Harvard Medical School provides results about the APACT Study. APACT Study is a phase III trial of adjuvant nab-paclitaxel plus gemcitabine versus gemcitabine for surgically resected pancreatic adenocarcinoma.

Results of the APACT Study: Phase III Trial of Adjuvant Nab-Paclitaxel

00:02:25

Don

3 years 83 Views

Share Add to Report 0 0

Embed (Iframe):

<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://oncologytube.com/videoEmbed/28855/results-of-the-apact-study-phase-iii-trial-of-adjuvant-nab-paclitaxel?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

Embed (Object):

<div class="embed-responsive embed-responsive-16by9"><object width="640" height="360"><param name="movie" value="https://oncologytube.com/videoEmbed/28855/results-of-the-apact-study-phase-iii-trial-of-adjuvant-nab-paclitaxel?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit="></param><param name="allowFullScreen" value="true"></param><param name="allowscriptaccess" value="always"></param><embed src="https://oncologytube.com/videoEmbed/28855/results-of-the-apact-study-phase-iii-trial-of-adjuvant-nab-paclitaxel?channelName=obr&modestbranding=1&showinfo=1&autoplay=&controls=1&loop=&mute=&t=0&objectFit=" allowscriptaccess="always" allowfullscreen="true" width="640" height="360"></embed></object></div>

Link (HTML):

<a href="https://oncologytube.com/v/28855?channelName=obr"><img src="https://oncologytubecom.cdn.ypt.me/videos/video_190625191448_6701/video_190625191448_6701.jpg?cache=15669161761678829655">Results of the APACT Study: Phase III Trial of Adjuvant Nab-Paclitaxel</a>

Link (BBCode):

[url=https://oncologytube.com/v/28855?channelName=obr][img]https://oncologytubecom.cdn.ypt.me/videos/video_190625191448_6701/video_190625191448_6701.jpg?cache=15669161761678829655[/img]Results of the APACT Study: Phase III Trial of Adjuvant Nab-Paclitaxel[/url]

Sign in now!

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

Category:

Pancreatic

Description:

Thomas A. Abrams, Senior Physician and Assistant Medical Professor at Harvard Medical School provides results about the APACT
Study. APACT Study is a phase III trial of adjuvant nab-paclitaxel plus
gemcitabine versus gemcitabine for surgically resected pancreatic
adenocarcinoma.